Skip to main content

Table 1 Patient demographics and follow-up observation time

From: Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

Characteristic

Value

Age (years), Mean (SD)

52.8 (16.1)

 Age: < 20

1.5%

 Age: 20–24

2.7%

 Age: 25–34

10.1%

 Age: 35–44

17.9%

 Age: 45–54

21.3%

 Age: 55–64

19.0%

 Age: 65–74

18.9%

 Age: 75–84

6.6%

 Age: 85+

2.1%

Gender: Female

73.0%

Insurance type: Medicare

41.2%

Charlson comorbidity index score, Mean (SD)

1.77 (2.55)

Follow-up time

 Proportion of patients with at least x days of follow-up

   ≥ 365 days

100.0%

   ≥ 730 days

62.6%

   ≥ 1095 days

36.3%

  Mean follow-up (days)

973

  Std. deviation

441

  Median follow-up (days)

879

Received a DMT any time during follow-up

35.0%

 Time (days) from MS diagnosis to receiving DMT, Mean (SD)

169 (258)